{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:44:29Z","timestamp":1790855069539,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T00:00:00Z","timestamp":1227830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00262-008-0631-1","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T08:06:42Z","timestamp":1227773202000},"page":"1085-1094","source":"Crossref","is-referenced-by-count":43,"title":["Prognostic significance of tumor iNOS and COX-2 in stage\u00a0III malignant cutaneous melanoma"],"prefix":"10.1007","volume":"58","author":[{"given":"C. Christian","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Egyh\u00e1zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Masucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Harlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Mougiakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Poschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liss","family":"Garberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Tuominen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Frostvik","family":"Stolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,28]]},"reference":[{"key":"631_CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.0022-202X.2005.23788.x","volume":"125","author":"LA Akslen","year":"2005","unstructured":"Akslen LA, Angelini S, Straume O, Bachmann IM, Molven A, Hemminki K, Kumar R (2005) BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J Invest Dermatol 125:312\u2013317","journal-title":"J Invest Dermatol"},{"key":"631_CR2","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001a) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"631_CR3","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A (2001b) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622\u20133634","journal-title":"J Clin Oncol"},{"key":"631_CR4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.prostaglandins.2007.03.003","volume":"83","author":"F Bianchini","year":"2007","unstructured":"Bianchini F, Massi D, Marconi C, Franchi A, Baroni G, Santucci M, Mannini A, Mugnai G, Calorini L (2007) Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. Prostaglandins Other Lipid Mediat 83:320\u2013328","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"631_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1600-065X.2000.917307.x","volume":"173","author":"C Bogdan","year":"2000","unstructured":"Bogdan C, Rollinghoff M, Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173:17\u201326","journal-title":"Immunol Rev"},{"key":"631_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1471-4906(03)00132-7","volume":"24","author":"V Bronte","year":"2003","unstructured":"Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P (2003) l-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 24:302\u2013306","journal-title":"Trends Immunol"},{"key":"631_CR7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ng1586","volume":"37","author":"Y Chudnovsky","year":"2005","unstructured":"Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA (2005) Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 37:745\u2013749","journal-title":"Nat Genet"},{"key":"631_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CMR.0b013e3280dec6ac","volume":"17","author":"BW Chwirot","year":"2007","unstructured":"Chwirot BW, Kuzbicki L (2007) Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours. Melanoma Res 17:139\u2013145","journal-title":"Melanoma Res"},{"key":"631_CR9","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1158\/1078-0432.CCR-03-0192","volume":"10","author":"F Cianchi","year":"2004","unstructured":"Cianchi F, Cortesini C, Fantappie O, Messerini L, Sardi I, Lasagna N, Perna F, Fabbroni V, Di Felice A, Perigli G, Mazzanti R, Masini E (2004) Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10:2694\u20132704","journal-title":"Clin Cancer Res"},{"key":"631_CR10","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.165.3.1582","volume":"165","author":"R Clancy","year":"2000","unstructured":"Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, Abramson SB (2000) Nitric oxide synthase\/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 165:1582\u20131587","journal-title":"J Immunol"},{"key":"631_CR11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Br\u00f6cker EB, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135\u20132147","journal-title":"N Engl J Med"},{"key":"631_CR12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"631_CR13","first-page":"303","volume":"61","author":"C Denkert","year":"2001","unstructured":"Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303\u2013308","journal-title":"Cancer Res"},{"key":"631_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000071371","volume":"37","author":"SM Dubinett","year":"2003","unstructured":"Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT (2003) Cyclooxygenase-2 in lung cancer. Prog Exp Tumor Res 37:138\u2013162","journal-title":"Prog Exp Tumor Res"},{"key":"631_CR15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063\u20131073","journal-title":"FASEB J"},{"key":"631_CR16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/gast.1996.v110.pm8613017","volume":"110","author":"RN Dubois","year":"1996","unstructured":"Dubois RN, Radhika A, Reddy BS, Entingh AJ (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259\u20131262","journal-title":"Gastroenterology"},{"key":"631_CR17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","volume":"107","author":"CE Eberhart","year":"1994","unstructured":"Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183\u20131188","journal-title":"Gastroenterology"},{"key":"631_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.21767","volume":"119","author":"S Ekmekcioglu","year":"2006","unstructured":"Ekmekcioglu S, Ellerhorst JA, Prieto VG, Johnson MM, Broemeling LD, Grimm EA (2006) Tumor iNOS predicts poor survival for stage III melanoma patients. Int J Cancer 119:861\u2013866","journal-title":"Int J Cancer"},{"key":"631_CR19","first-page":"4768","volume":"6","author":"S Ekmekcioglu","year":"2000","unstructured":"Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA (2000) Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6:4768\u20134775","journal-title":"Clin Cancer Res"},{"key":"631_CR20","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1038\/sj.onc.1209419","volume":"25","author":"JA Ellerhorst","year":"2006","unstructured":"Ellerhorst JA, Ekmekcioglu S, Johnson MK, Cooke CP, Johnson MM, Grimm EA (2006) Regulation of iNOS by the p44\/42 mitogen-activated protein kinase pathway in human melanoma. Oncogene 25:3956\u20133962","journal-title":"Oncogene"},{"key":"631_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10555-005-5865-1","volume":"24","author":"VC Gray-Schopfer","year":"2004","unstructured":"Gray-Schopfer VC, a Dias S, Marais R (2004) The role of B-RAF in melanoma. Cancer Metastasis Rev 24:165\u2013183","journal-title":"Cancer Metastasis Rev"},{"key":"631_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0923-2494(91)90103-P","volume":"142","author":"JB Hibbs Jr","year":"1991","unstructured":"Hibbs JB Jr (1991) Synthesis of nitric oxide from l-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res Immunol 142:565\u2013569 discussion 96\u20138","journal-title":"Res Immunol"},{"key":"631_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-291X(88)80015-9","volume":"157","author":"JB Hibbs Jr","year":"1988","unstructured":"Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87\u201394","journal-title":"Biochem Biophys Res Commun"},{"key":"631_CR24","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","volume":"84","author":"LJ Ignarro","year":"1987","unstructured":"Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265\u20139269","journal-title":"Proc Natl Acad Sci USA"},{"key":"631_CR25","first-page":"184","volume":"60","author":"M Jaiswal","year":"2000","unstructured":"Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60:184\u2013190","journal-title":"Cancer Res"},{"key":"631_CR26","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1038\/sj.onc.1206909","volume":"22","author":"R Kumar","year":"2003","unstructured":"Kumar R, Angelini S, Hemminki K (2003) Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Oncogene 22:9217\u20139224","journal-title":"Oncogene"},{"key":"631_CR27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1096-9896(200106)194:2<194::AID-PATH851>3.0.CO;2-S","volume":"194","author":"D Massi","year":"2001","unstructured":"Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M (2001) Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. J Pathol 194:194\u2013200","journal-title":"J Pathol"},{"key":"631_CR28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720\u2013724","journal-title":"Nature"},{"key":"631_CR29","first-page":"4356","volume":"59","author":"MA Molina","year":"1999","unstructured":"Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59:4356\u20134362","journal-title":"Cancer Res"},{"key":"631_CR30","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/01.ASN.0000136425.75041.9C","volume":"15","author":"T Ostendorf","year":"2004","unstructured":"Ostendorf T, Van Roeyen C, Westenfeld R, Gawlik A, Kitahara M, De Heer E, Kerjaschki D, Floege J, Ketteler M (2004) Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors. J Am Soc Nephrol 15:2307\u20132319","journal-title":"J Am Soc Nephrol"},{"key":"631_CR31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.brainresrev.2004.12.024","volume":"48","author":"P Patrignani","year":"2005","unstructured":"Patrignani P, Tacconelli S, Sciulli MG, Capone ML (2005) New insights into COX-2 biology and inhibition. Brain Res Brain Res Rev 48:352\u2013359","journal-title":"Brain Res Brain Res Rev"},{"key":"631_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mrfmmm.2004.05.022","volume":"555","author":"CV Rao","year":"2004","unstructured":"Rao CV (2004) Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555:107\u2013119","journal-title":"Mutat Res"},{"key":"631_CR33","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, Ochoa AC (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64:5839\u20135849","journal-title":"Cancer Res"},{"key":"631_CR34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.seminoncol.2004.03.018","volume":"31","author":"DL Rousseau Jr","year":"2004","unstructured":"Rousseau DL Jr, Gershenwald JE (2004) The new staging system for cutaneous melanoma in the era of lymphatic mapping. Semin Oncol 31:415\u2013425","journal-title":"Semin Oncol"},{"key":"631_CR35","first-page":"318","volume":"61","author":"O Salvucci","year":"2001","unstructured":"Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A (2001) Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 61:318\u2013326","journal-title":"Cancer Res"},{"key":"631_CR36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00008390-200209000-00006","volume":"12","author":"K Satyamoorthy","year":"2002","unstructured":"Satyamoorthy K, Li G, Van Belle PA, Elder DE, Herlyn M (2002) A versatile method for the removal of melanin from ribonucleic acids in melanocytic cells. Melanoma Res 12:449\u2013452","journal-title":"Melanoma Res"},{"key":"631_CR37","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.onc.1209379","volume":"25","author":"M Sensi","year":"2006","unstructured":"Sensi M, Nicolini G, Petti C, Bersani I, Lozupone F, Molla A, Vegetti C, Nonaka D, Mortarini R, Parmiani G, Fais S, Anichini A (2006) Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma. Oncogene 25:3357\u20133364","journal-title":"Oncogene"},{"key":"631_CR38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1074\/jbc.M310821200","volume":"279","author":"CH Tang","year":"2004","unstructured":"Tang CH, Grimm EA (2004) Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines. J Biol Chem 279:288\u2013298","journal-title":"J Biol Chem"},{"key":"631_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjc.1995.274","volume":"72","author":"LL Thomsen","year":"1995","unstructured":"Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41\u201344","journal-title":"Br J Cancer"},{"key":"631_CR40","first-page":"1352","volume":"54","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54:1352\u20131354","journal-title":"Cancer Res"},{"key":"631_CR41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-9098(199811)69:3<168::AID-JSO9>3.0.CO;2-0","volume":"69","author":"K Uefuji","year":"1998","unstructured":"Uefuji K, Ichikura T, Mochizuki H, Shinomiya N (1998) Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surg Oncol 69:168\u2013172","journal-title":"J Surg Oncol"},{"key":"631_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","volume":"55","author":"D Wang","year":"2006","unstructured":"Wang D, Dubois RN (2006) Prostaglandins and cancer. Gut 55:115\u2013122","journal-title":"Gut"},{"key":"631_CR43","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","volume":"64","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D, Springer CJ, Marais R (2004) V599\u00a0EB-RAF is an oncogene in melanocytes. Cancer Res 64:2338\u20132342","journal-title":"Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-008-0631-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-008-0631-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-008-0631-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:33:17Z","timestamp":1558701197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-008-0631-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,28]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s00262-008-0631-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,28]]}}}